Barclays Maintains Underweight on Clarivate, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Manav Patnaik maintains an Underweight rating on Clarivate (NYSE:CLVT) and lowers the price target from $7 to $6.
February 28, 2024 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays maintains an Underweight rating on Clarivate and lowers the price target from $7 to $6.
The reduction in price target by Barclays, a major financial institution, signals a bearish outlook on Clarivate's stock. This could lead to a decrease in investor confidence and potentially lower stock prices in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100